The statements below are read from MAHAMAYA LIFESCIENCES LIMITED’s filed results, 2 filed quarters and 5 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed May 26, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|
| Sales | 163 | 166 | — |
| 148 | 149 | — | |
| Operating profit | 15.1 | 17.3 | — |
| OPM % | 9.3% | 10.4% | — |
| Other income | 1.27 | 0.60 | — |
| Interest | 3.85 | 4.29 | — |
| Depreciation | 1.10 | 1.14 | — |
| Profit before tax | 11.4 | 12.5 | — |
| Tax % | 26.7% | 34.6% | — |
| Net profit | 8.37 | 8.15 | — |
| EPS (₹) | 4.71 | 3.72 | — |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
